Global Self-Monitoring Blood Glucose System Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Self-Monitoring Blood Glucose System market report explains the definition, types, applications, major countries, and major players of the Self-Monitoring Blood Glucose System market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Abbott (US)

    • Medtronic (Ireland), Dexcom (US)

    • Ypsomed (Switzerland)

    • ARKRAY (Japan)

    • Nova Biomedical (US)

    • Prodigy Diabetes Care (US)

    • Ascensia (Switzerland)

    • ACON Laboratories (US)

    • Nipro (Japan), Sanofi (France)

    • B Braun (Germany)

    • Roche (Switzerland)

    • LifeScan (US)

    By Type:

    • Blood Glucose meters

    • Testing strips

    • Lancets & Lancing Devices

    By End-User:

    • Type 2 Diabetes

    • Type 1 Diabetes

    • Gestational Diabetes

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Self-Monitoring Blood Glucose System Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Self-Monitoring Blood Glucose System Outlook to 2028- Original Forecasts

    • 2.2 Self-Monitoring Blood Glucose System Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Self-Monitoring Blood Glucose System Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Self-Monitoring Blood Glucose System Market- Recent Developments

    • 6.1 Self-Monitoring Blood Glucose System Market News and Developments

    • 6.2 Self-Monitoring Blood Glucose System Market Deals Landscape

    7 Self-Monitoring Blood Glucose System Raw Materials and Cost Structure Analysis

    • 7.1 Self-Monitoring Blood Glucose System Key Raw Materials

    • 7.2 Self-Monitoring Blood Glucose System Price Trend of Key Raw Materials

    • 7.3 Self-Monitoring Blood Glucose System Key Suppliers of Raw Materials

    • 7.4 Self-Monitoring Blood Glucose System Market Concentration Rate of Raw Materials

    • 7.5 Self-Monitoring Blood Glucose System Cost Structure Analysis

      • 7.5.1 Self-Monitoring Blood Glucose System Raw Materials Analysis

      • 7.5.2 Self-Monitoring Blood Glucose System Labor Cost Analysis

      • 7.5.3 Self-Monitoring Blood Glucose System Manufacturing Expenses Analysis

    8 Global Self-Monitoring Blood Glucose System Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Self-Monitoring Blood Glucose System Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Self-Monitoring Blood Glucose System Export by Region (Top 10 Countries) (2017-2028)

    9 Global Self-Monitoring Blood Glucose System Market Outlook by Types and Applications to 2022

    • 9.1 Global Self-Monitoring Blood Glucose System Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Blood Glucose meters Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Testing strips Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Lancets & Lancing Devices Consumption and Growth Rate (2017-2022)

    • 9.2 Global Self-Monitoring Blood Glucose System Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Type 1 Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Gestational Diabetes Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Self-Monitoring Blood Glucose System Market Analysis and Outlook till 2022

    • 10.1 Global Self-Monitoring Blood Glucose System Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.2.2 Canada Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.2.3 Mexico Self-Monitoring Blood Glucose System Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.3.2 UK Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.3.3 Spain Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.3.4 Belgium Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.3.5 France Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.3.6 Italy Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.3.7 Denmark Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.3.8 Finland Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.3.9 Norway Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.3.10 Sweden Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.3.11 Poland Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.3.12 Russia Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.3.13 Turkey Self-Monitoring Blood Glucose System Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.4.2 Japan Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.4.3 India Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.4.4 South Korea Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.4.5 Pakistan Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.4.6 Bangladesh Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.4.7 Indonesia Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.4.8 Thailand Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.4.9 Singapore Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.4.10 Malaysia Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.4.11 Philippines Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.4.12 Vietnam Self-Monitoring Blood Glucose System Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.5.2 Colombia Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.5.3 Chile Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.5.4 Argentina Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.5.5 Venezuela Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.5.6 Peru Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.5.7 Puerto Rico Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.5.8 Ecuador Self-Monitoring Blood Glucose System Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.6.2 Kuwait Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.6.3 Oman Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.6.4 Qatar Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Self-Monitoring Blood Glucose System Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.7.2 South Africa Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.7.3 Egypt Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.7.4 Algeria Self-Monitoring Blood Glucose System Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Self-Monitoring Blood Glucose System Consumption (2017-2022)

      • 10.8.2 New Zealand Self-Monitoring Blood Glucose System Consumption (2017-2022)

    11 Global Self-Monitoring Blood Glucose System Competitive Analysis

    • 11.1 Abbott (US)

      • 11.1.1 Abbott (US) Company Details

      • 11.1.2 Abbott (US) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Abbott (US) Self-Monitoring Blood Glucose System Main Business and Markets Served

      • 11.1.4 Abbott (US) Self-Monitoring Blood Glucose System Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Medtronic (Ireland), Dexcom (US)

      • 11.2.1 Medtronic (Ireland), Dexcom (US) Company Details

      • 11.2.2 Medtronic (Ireland), Dexcom (US) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Medtronic (Ireland), Dexcom (US) Self-Monitoring Blood Glucose System Main Business and Markets Served

      • 11.2.4 Medtronic (Ireland), Dexcom (US) Self-Monitoring Blood Glucose System Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Ypsomed (Switzerland)

      • 11.3.1 Ypsomed (Switzerland) Company Details

      • 11.3.2 Ypsomed (Switzerland) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Ypsomed (Switzerland) Self-Monitoring Blood Glucose System Main Business and Markets Served

      • 11.3.4 Ypsomed (Switzerland) Self-Monitoring Blood Glucose System Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 ARKRAY (Japan)

      • 11.4.1 ARKRAY (Japan) Company Details

      • 11.4.2 ARKRAY (Japan) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 ARKRAY (Japan) Self-Monitoring Blood Glucose System Main Business and Markets Served

      • 11.4.4 ARKRAY (Japan) Self-Monitoring Blood Glucose System Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Nova Biomedical (US)

      • 11.5.1 Nova Biomedical (US) Company Details

      • 11.5.2 Nova Biomedical (US) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Nova Biomedical (US) Self-Monitoring Blood Glucose System Main Business and Markets Served

      • 11.5.4 Nova Biomedical (US) Self-Monitoring Blood Glucose System Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Prodigy Diabetes Care (US)

      • 11.6.1 Prodigy Diabetes Care (US) Company Details

      • 11.6.2 Prodigy Diabetes Care (US) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Prodigy Diabetes Care (US) Self-Monitoring Blood Glucose System Main Business and Markets Served

      • 11.6.4 Prodigy Diabetes Care (US) Self-Monitoring Blood Glucose System Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Ascensia (Switzerland)

      • 11.7.1 Ascensia (Switzerland) Company Details

      • 11.7.2 Ascensia (Switzerland) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Ascensia (Switzerland) Self-Monitoring Blood Glucose System Main Business and Markets Served

      • 11.7.4 Ascensia (Switzerland) Self-Monitoring Blood Glucose System Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 ACON Laboratories (US)

      • 11.8.1 ACON Laboratories (US) Company Details

      • 11.8.2 ACON Laboratories (US) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 ACON Laboratories (US) Self-Monitoring Blood Glucose System Main Business and Markets Served

      • 11.8.4 ACON Laboratories (US) Self-Monitoring Blood Glucose System Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Nipro (Japan), Sanofi (France)

      • 11.9.1 Nipro (Japan), Sanofi (France) Company Details

      • 11.9.2 Nipro (Japan), Sanofi (France) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Nipro (Japan), Sanofi (France) Self-Monitoring Blood Glucose System Main Business and Markets Served

      • 11.9.4 Nipro (Japan), Sanofi (France) Self-Monitoring Blood Glucose System Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 B Braun (Germany)

      • 11.10.1 B Braun (Germany) Company Details

      • 11.10.2 B Braun (Germany) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 B Braun (Germany) Self-Monitoring Blood Glucose System Main Business and Markets Served

      • 11.10.4 B Braun (Germany) Self-Monitoring Blood Glucose System Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Roche (Switzerland)

      • 11.11.1 Roche (Switzerland) Company Details

      • 11.11.2 Roche (Switzerland) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Roche (Switzerland) Self-Monitoring Blood Glucose System Main Business and Markets Served

      • 11.11.4 Roche (Switzerland) Self-Monitoring Blood Glucose System Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 LifeScan (US)

      • 11.12.1 LifeScan (US) Company Details

      • 11.12.2 LifeScan (US) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 LifeScan (US) Self-Monitoring Blood Glucose System Main Business and Markets Served

      • 11.12.4 LifeScan (US) Self-Monitoring Blood Glucose System Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    12 Global Self-Monitoring Blood Glucose System Market Outlook by Types and Applications to 2028

    • 12.1 Global Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Blood Glucose meters Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Testing strips Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Lancets & Lancing Devices Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Gestational Diabetes Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Self-Monitoring Blood Glucose System Market Analysis and Outlook to 2028

    • 13.1 Global Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.2.2 Canada Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.3.2 UK Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.3.3 Spain Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.3.5 France Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.3.6 Italy Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.3.8 Finland Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.3.9 Norway Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.3.11 Poland Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.3.12 Russia Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.4.2 Japan Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.4.3 India Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.5.3 Chile Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.5.6 Peru Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.6.3 Oman Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Self-Monitoring Blood Glucose System Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Self-Monitoring Blood Glucose System

    • Figure of Self-Monitoring Blood Glucose System Picture

    • Table Global Self-Monitoring Blood Glucose System Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Self-Monitoring Blood Glucose System Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Blood Glucose meters Consumption and Growth Rate (2017-2022)

    • Figure Global Testing strips Consumption and Growth Rate (2017-2022)

    • Figure Global Lancets & Lancing Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Type 1 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Gestational Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Self-Monitoring Blood Glucose System Consumption by Country (2017-2022)

    • Table North America Self-Monitoring Blood Glucose System Consumption by Country (2017-2022)

    • Figure United States Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Canada Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Mexico Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Table Europe Self-Monitoring Blood Glucose System Consumption by Country (2017-2022)

    • Figure Germany Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure UK Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Spain Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Belgium Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure France Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Italy Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Denmark Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Finland Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Norway Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Sweden Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Poland Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Russia Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Turkey Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Table APAC Self-Monitoring Blood Glucose System Consumption by Country (2017-2022)

    • Figure China Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Japan Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure India Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure South Korea Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Thailand Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Singapore Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Philippines Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Table South America Self-Monitoring Blood Glucose System Consumption by Country (2017-2022)

    • Figure Brazil Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Colombia Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Chile Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Argentina Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Peru Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Table GCC Self-Monitoring Blood Glucose System Consumption by Country (2017-2022)

    • Figure Bahrain Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Oman Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Qatar Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Table Africa Self-Monitoring Blood Glucose System Consumption by Country (2017-2022)

    • Figure Nigeria Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure South Africa Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Egypt Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure Algeria Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Table Oceania Self-Monitoring Blood Glucose System Consumption by Country (2017-2022)

    • Figure Australia Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Self-Monitoring Blood Glucose System Consumption and Growth Rate (2017-2022)

    • Table Abbott (US) Company Details

    • Table Abbott (US) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott (US) Self-Monitoring Blood Glucose System Main Business and Markets Served

    • Table Abbott (US) Self-Monitoring Blood Glucose System Product Portfolio

    • Table Medtronic (Ireland), Dexcom (US) Company Details

    • Table Medtronic (Ireland), Dexcom (US) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic (Ireland), Dexcom (US) Self-Monitoring Blood Glucose System Main Business and Markets Served

    • Table Medtronic (Ireland), Dexcom (US) Self-Monitoring Blood Glucose System Product Portfolio

    • Table Ypsomed (Switzerland) Company Details

    • Table Ypsomed (Switzerland) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ypsomed (Switzerland) Self-Monitoring Blood Glucose System Main Business and Markets Served

    • Table Ypsomed (Switzerland) Self-Monitoring Blood Glucose System Product Portfolio

    • Table ARKRAY (Japan) Company Details

    • Table ARKRAY (Japan) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

    • Table ARKRAY (Japan) Self-Monitoring Blood Glucose System Main Business and Markets Served

    • Table ARKRAY (Japan) Self-Monitoring Blood Glucose System Product Portfolio

    • Table Nova Biomedical (US) Company Details

    • Table Nova Biomedical (US) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nova Biomedical (US) Self-Monitoring Blood Glucose System Main Business and Markets Served

    • Table Nova Biomedical (US) Self-Monitoring Blood Glucose System Product Portfolio

    • Table Prodigy Diabetes Care (US) Company Details

    • Table Prodigy Diabetes Care (US) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prodigy Diabetes Care (US) Self-Monitoring Blood Glucose System Main Business and Markets Served

    • Table Prodigy Diabetes Care (US) Self-Monitoring Blood Glucose System Product Portfolio

    • Table Ascensia (Switzerland) Company Details

    • Table Ascensia (Switzerland) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ascensia (Switzerland) Self-Monitoring Blood Glucose System Main Business and Markets Served

    • Table Ascensia (Switzerland) Self-Monitoring Blood Glucose System Product Portfolio

    • Table ACON Laboratories (US) Company Details

    • Table ACON Laboratories (US) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

    • Table ACON Laboratories (US) Self-Monitoring Blood Glucose System Main Business and Markets Served

    • Table ACON Laboratories (US) Self-Monitoring Blood Glucose System Product Portfolio

    • Table Nipro (Japan), Sanofi (France) Company Details

    • Table Nipro (Japan), Sanofi (France) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nipro (Japan), Sanofi (France) Self-Monitoring Blood Glucose System Main Business and Markets Served

    • Table Nipro (Japan), Sanofi (France) Self-Monitoring Blood Glucose System Product Portfolio

    • Table B Braun (Germany) Company Details

    • Table B Braun (Germany) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

    • Table B Braun (Germany) Self-Monitoring Blood Glucose System Main Business and Markets Served

    • Table B Braun (Germany) Self-Monitoring Blood Glucose System Product Portfolio

    • Table Roche (Switzerland) Company Details

    • Table Roche (Switzerland) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche (Switzerland) Self-Monitoring Blood Glucose System Main Business and Markets Served

    • Table Roche (Switzerland) Self-Monitoring Blood Glucose System Product Portfolio

    • Table LifeScan (US) Company Details

    • Table LifeScan (US) Self-Monitoring Blood Glucose System Sales, Price, Value and Gross Profit (2017-2022)

    • Table LifeScan (US) Self-Monitoring Blood Glucose System Main Business and Markets Served

    • Table LifeScan (US) Self-Monitoring Blood Glucose System Product Portfolio

    • Figure Global Blood Glucose meters Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Testing strips Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lancets & Lancing Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gestational Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Self-Monitoring Blood Glucose System Consumption Forecast by Country (2022-2028)

    • Table North America Self-Monitoring Blood Glucose System Consumption Forecast by Country (2022-2028)

    • Figure United States Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Self-Monitoring Blood Glucose System Consumption Forecast by Country (2022-2028)

    • Figure Germany Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Self-Monitoring Blood Glucose System Consumption Forecast by Country (2022-2028)

    • Figure China Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Self-Monitoring Blood Glucose System Consumption Forecast by Country (2022-2028)

    • Figure Brazil Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Self-Monitoring Blood Glucose System Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Self-Monitoring Blood Glucose System Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Self-Monitoring Blood Glucose System Consumption Forecast by Country (2022-2028)

    • Figure Australia Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Self-Monitoring Blood Glucose System Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.